
CoreTech Limited (MLCOT) | Financial Analysis & Statements
CoreTech Limited | Small-cap | Healthcare
CoreTech Limited | Small-cap | Healthcare
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Income Metrics
Balance Sheet Metrics
Total Assets
128.1K
Total Liabilities
655.3K
Shareholders Equity
-527.2K
Cash Flow Metrics
Revenue & Profitability Trend
CoreTech Limited Income Statement From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Revenue | 15.4K | 1 | 1 | 870 | 4.1K |
Cost of Goods Sold | 73.6K | 90.0K | 43.0K | 112.6K | 95.6K |
Gross Profit | -58.2K | -90.0K | -43.0K | -111.7K | -91.5K |
Gross Margin % | -379.3% | -9,001,000.0% | -4,300,500.0% | -12,837.4% | -2,247.5% |
Operating Expenses | |||||
Research & Development | - | - | - | - | - |
Selling, General & Administrative | - | - | 32.8K | 53.1K | 27.4K |
Other Operating Expenses | -3.2K | - | -22.5K | -489 | -946 |
Total Operating Expenses | -3.2K | 0 | 10.3K | 52.6K | 26.5K |
Operating Income | -55.0K | -98.8K | -33.7K | -141.7K | -121.1K |
Operating Margin % | -358.4% | -9,878,500.0% | -3,368,600.0% | -16,289.4% | -2,973.7% |
Non-Operating Items | |||||
Interest Income | 90.4K | - | 1 | 1 | 1 |
Interest Expense | 14.3K | 9.4K | - | - | 1.4K |
Other Non-Operating Income | - | - | - | - | - |
Pre-tax Income | 21.1K | -94.7K | -56.1K | -164.2K | -122.5K |
Income Tax | - | - | - | - | - |
Effective Tax Rate % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Net Income | 21.1K | -94.7K | -56.1K | -164.2K | -122.5K |
Net Margin % | 137.3% | -9,474,100.0% | -5,614,400.0% | -18,870.8% | -3,007.3% |
Key Metrics | |||||
EBITDA | 35.4K | -90.0K | -20.5K | -111.2K | -90.6K |
EPS (Basic) | - | - | €0.00 | €-0.05 | €-0.04 |
EPS (Diluted) | - | - | €0.00 | €-0.05 | €-0.04 |
Basic Shares Outstanding | - | - | 13406759 | 3325877 | 3325877 |
Diluted Shares Outstanding | - | - | 13406759 | 3325877 | 3325877 |
Income Statement Trend
CoreTech Limited Balance Sheet From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Assets | |||||
Current Assets | |||||
Cash & Equivalents | 12.0K | 73.3K | - | 252 | 1.1K |
Short-term Investments | - | 85.7K | 100 | 100 | 100 |
Accounts Receivable | - | - | - | - | - |
Inventory | - | - | - | - | 13.1K |
Other Current Assets | - | - | - | - | - |
Total Current Assets | 13.0K | 167.0K | 13.7K | 31.9K | 38.6K |
Non-Current Assets | |||||
Property, Plant & Equipment | - | - | - | - | - |
Goodwill | - | - | 0 | 13.1K | 43.7K |
Intangible Assets | - | - | 91.6K | 13.1K | 43.7K |
Long-term Investments | - | - | - | - | - |
Other Non-Current Assets | - | - | - | 22.5K | 1.4K |
Total Non-Current Assets | 0 | 0 | 0 | 35.6K | 45.0K |
Total Assets | 13.0K | 167.0K | 13.7K | 67.5K | 83.6K |
Liabilities | |||||
Current Liabilities | |||||
Accounts Payable | 32.8K | 59.3K | 72.1K | 169.0K | 137.1K |
Short-term Debt | - | - | - | - | - |
Current Portion of Long-term Debt | - | - | - | - | - |
Other Current Liabilities | - | - | - | - | - |
Total Current Liabilities | 32.8K | 59.3K | 72.1K | 177.4K | 140.6K |
Non-Current Liabilities | |||||
Long-term Debt | 728 | 149.4K | 23.6K | 814.3K | 720.1K |
Deferred Tax Liabilities | - | - | - | - | - |
Other Non-Current Liabilities | - | - | 91.6K | - | 4.0K |
Total Non-Current Liabilities | 728 | 149.4K | 23.6K | 836.7K | 725.5K |
Total Liabilities | 33.5K | 208.7K | 95.7K | 1.0M | 866.1K |
Equity | |||||
Common Stock | 167.8K | 167.8K | 1.2M | 303.8K | 303.8K |
Retained Earnings | -707.4K | -728.5K | -1.7M | -1.7M | -1.5M |
Treasury Stock | - | - | - | - | - |
Other Equity | - | - | - | - | - |
Total Shareholders Equity | -20.6K | -41.7K | -81.9K | -946.7K | -782.5K |
Key Metrics | |||||
Total Debt | 728 | 149.4K | 23.6K | 814.3K | 720.1K |
Working Capital | -19.9K | 107.7K | -58.3K | -145.5K | -102.1K |
Balance Sheet Composition
CoreTech Limited Cash Flow Statement
No cash flow data available.
CoreTech Limited Key Financial Ratios
Valuation Ratios
Price to Sales
197.86
Profitability Ratios
Profit Margin
137.36%
Operating Margin
-405.84%
Return on Equity
-102.42%
Return on Assets
-43.28%
Financial Health
Current Ratio
0.40
Debt to Equity
-0.95
Beta
-0.14
Per Share Data
EPS (TTM)
€0.00
Book Value per Share
€-0.01
Peer Financial Comparison
Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
---|---|---|---|---|---|---|
mlcot | 3.0M | - | - | -102.42% | 137.36% | -0.95 |
Ipsen S.A | 9.5B | 21.49 | 2.26 | 10.89% | 11.91% | 22.74 |
Vetoquinol S.A | 887.3M | 15.10 | 1.54 | 10.64% | 10.88% | 3.67 |
AB Science S.A | 83.1M | -8.60 | - | 32.97% | 116.42% | -0.78 |
Boiron S.A | 392.4M | 34.77 | 1.04 | 2.95% | 2.33% | 3.96 |
Euroapi S.A.S.U | 301.9M | 8.84 | 0.40 | -13.49% | -14.08% | 7.17 |
Financial data is updated regularly. All figures are in the company's reporting currency.